Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Equities researchers at Roth Capital increased their Q4 2024 EPS estimates for Green Thumb Industries in a report issued on Thursday, May 9th. Roth Capital analyst S. Fortune now expects that the company will post earnings of $0.10 per share for the quarter, up from their prior estimate of $0.08. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.26 per share. Roth Capital also issued estimates for Green Thumb Industries' Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.09 EPS, Q4 2025 earnings at $0.09 EPS and FY2025 earnings at $0.31 EPS.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.04). Green Thumb Industries had a net margin of 3.44% and a return on equity of 2.13%. The company had revenue of $278.23 million for the quarter, compared to analysts' expectations of $270.07 million.
A number of other brokerages have also recently weighed in on GTBIF. Wedbush upped their price objective on shares of Green Thumb Industries from $15.00 to $16.00 and gave the stock an "outperform" rating in a report on Friday. Needham & Company LLC increased their price target on shares of Green Thumb Industries from $15.50 to $17.00 and gave the company a "buy" rating in a report on Thursday.
Read Our Latest Report on GTBIF
Green Thumb Industries Trading Up 0.9 %
GTBIF traded up $0.12 during midday trading on Friday, reaching $12.93. The company's stock had a trading volume of 554,098 shares, compared to its average volume of 530,560. The firm has a market capitalization of $2.72 billion, a price-to-earnings ratio of 85.40 and a beta of 1.58. Green Thumb Industries has a 1 year low of $6.42 and a 1 year high of $16.33. The stock's 50-day moving average is $13.10 and its 200-day moving average is $11.94.
About Green Thumb Industries
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Read More
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
